Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

the CVD-REAL Investigators and Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data'. Together they form a unique fingerprint.

Medicine & Life Sciences